Edwards Carladenise Armbrister
SEC Form 4 insider trading activity
Edwards Carladenise Armbrister has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: May 19, 2026.
On the most recent filing, Edwards Carladenise Armbrister is listed as Director at CLOVER HEALTH INVESTMENTS, CORP. /DE. Inside the rolling window, Edwards Carladenise Armbrister reported no open-market purchases and 1 open-market sale totaling $230K in CLOV.
Companies traded
Other insiders at CLOV
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$230K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Edwards Carladenise Armbrister made?
Edwards Carladenise Armbrister has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Edwards Carladenise Armbrister trade?
Edwards Carladenise Armbrister has filed SEC Form 4 disclosures for 1 company, including CLOV.
When was Edwards Carladenise Armbrister's most recent SEC Form 4 filing?
Edwards Carladenise Armbrister's most recent SEC Form 4 filing on Tracefour is dated May 19, 2026.
What is Edwards Carladenise Armbrister's total buy and sell value in the current window?
Inside the rolling retention window, Edwards Carladenise Armbrister bought $0 and sold $230K based on SEC Form 4 filings.
What was Edwards Carladenise Armbrister's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 67,160 CLOV shares on 2026-05-18, worth $230K, per SEC Form 4 filings.